Lenalidomide with dexamethasone treatment for relapsed/refractory myeloma patients in Korea—experience from 110 patients

Overview of attention for article published in Annals of Hematology, September 2013

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 40 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 14,838 followers.

Korean working party reports response rate of 43.6% for #Revlimid/dex in patients with relapsed/refractory #myeloma (http://t.co/qayF0yjSmF)

Reply Repost Favourite